In vivo antiviral activity of an interferon β production-promoting fraction from the marine brown alga, Sargassum hemiphyllum (Turner) C. Agardh

Botanica Marina

Volumn 48, Issue 1, 2005, Pages 84-86

  Nakano, Takanari ^a,b   Kamei, Yuto ^a  

^a SAGA UNIVERSITY   (Japan)

^b YAMASA CORPORATION   (Japan)

Author keywords

Antiviral activity; Aujeszky's disease virus; Immunomodulator; Interferon ; Sargassum hemiphyllum

Indexed keywords

BROWN ALGA;

ALGAE; AUJESZKY DISEASE VIRUS; HUMAN PARAINFLUENZA VIRUS 1; PHAEOPHYCEAE; SARGASSUM HEMIPHYLLUM; SENDAI VIRUS;

EID: 17144416163     PISSN: 00068055     EISSN: None     Source Type: Journal    
DOI: 10.1515/BOT.2005.008     Document Type: Article

References (16)

1. Baron, S., S.K. Tyring, W.R. Jr. Fleischmann, D.H. Coppenhaver, D.W. Niesel, G.R. Klimpel, G.J. Stanton and T.K. Hughes. 1991. The interferons. Mechanisms of action and clinical applications. J. Am. Med. Assoc. 266: 1375-1383.
2. Burleson G.R. and G.G. Burleson. 1995. Bioassay of interferons. Methods in Immunotoxicol. 1: 345-356.
3. Hiscott, J., P. Pitha, P. Genin, H. Nguyen, C. Heylbroeck, Y. Mamane, M. Algarte and R. Lin. 1999. Triggering the interferon response: the role of IRF-3 transcription factor. J. Interferon Cytokine Res. 19: 1-13.
4. Kimura, M., L.A. Toth, H. Agostini, A.B. Cady, J.A. Majde and J.M. Krueger. 1994. Comparison of acute phase responses induced in rabbits by lipopolysaccharide and double-stranded RNA. Am. J. Physiol. 267: R1596-1605.
5. Kótai, A., T. Gánti and I. Mecs. 1975. Polycationic modified polypeptides enhancing poly (I:C) induced viral resistance. Experientia 31: 1165-1167.
6. Levy, H.B., G. Baer, S. Baron, C.E. Buckler, C.J. Gibbs, M.J. Iadarola, W.T. London and J. Rice. 1975. A modified polyriboinosinic-polyribocytidylic acid complex that induces interferon in primates. J. Infect. Dis. 132: 434-439.
7. Lu, Y., M. Wambach, M.G. Katze, R.M. Krug. 1995. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214: 222-228.
8. Meager, A., J. Shuttleworth, M.D. Just, P. Boseley and J. Morser. 1982. The effect of hypertonic salt on interferon and interferon mRNA synthesis in human MG63 cells. J. Gen. Virol. 59: 177-181.
9. Nakano, T., T. Noro and Y. Kamei. 1997. In vitro promoting activity of human interferon β production by extracts of marine algae from Japan. Cytotechnology 25: 239-241.
10. Osada, K., K. Nagira, K. Teruya, H. Tachibana, S. Shirahata and H. Murakami. 1993. Enhancement of interferon-β production with sphingomyelin from fermented milk. Biotherapy. 7: 115-123.
11. Talmadge, J.E., J. Adams, H. Phillips, M. Collins, B. Lenz, M. Schneider, E. Schlick, R. Ruffmann, R.H. Wiltrout and M.A. Chirigos. 1985a. Immunomodulatory effects in mice of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose. Cancer Res. 45: 1058-1065.
12. Talmadge, J.E., J. Adams, H. Phillips, M. Collins, B. Lenz, M. Schneider and M. Chirigos. 1985b. Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-L-lysine solubilized by carboxymethylcellulose. Cancer Res. 45: 1066-1072.
13. Tan, Y.H., J.A. Armstrong, Y.H. Ke and M. Ho. 1970. Regulation of cellular interferon production: enhancement by antimetabolites. Proc. Natl. Acad. Sci. USA. 67: 464-471.
14. Visser, N. 1997. Vaccination strategies for improving the efficacy of programs to eradicate Aujeszky's disease virus. Vet. Microbiol. 55: 61-74.
15. Wong, J.P., E.G. Saravolac, D. Sabuda, H.B. Levy and M. Kende. 1995. Prophylactic and therapeutic efficacies of poly(IC.LC) against respiratory influenza A virus infection in mice. Antimicrob. Agents. Chemother. 39: 2574-2576.
16. Yamamoto, M.M., Y. Mori, K. Osada and H. Murakami. 1995. Enhancement of production of IgM and interferon-β in human cell lines by poly-lysine. Biosci. Biotechnol. Biochem. 59: 1842-1845.